Newer antibiotic agents acting on gram-negative organisms.
D000284:Administration, Oral; D000667:Ampicillin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy; D002228:Carbenicillin / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use / Q000652:urine; D002506:Cephalexin / Q000494:pharmacology / Q000627:therapeutic use; D002981:Clindamycin / Q000494:pharmacology; D004755:Enterobacteriaceae / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D004952:Esters; D007709:Klebsiella / Q000187:drug effects; D010403:Penicillin Resistance; D011511:Proteus / Q000187:drug effects; D011513:Proteus mirabilis / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D012475:Salmonella / Q000187:drug effects; D012705:Serratia / Q000187:drug effects; D014552:Urinary Tract Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D004952:Esters; D002981:Clindamycin; D000667:Ampicillin; D002228:Carbenicillin; D002506:Cephalexin